Product Details
Alternative Name: | Autocamtide-2-related inhibitory peptide (myristoylated) |
|
Sequence: | N-Myr-Lys-Lys-Ala-Leu-Arg-Arg-Gln-Glu-Ala-Val-Asp-Ala-Leu |
|
MW: | 1708.1 |
|
Source: | Synthetic. |
|
Formulation: | Lyophilized. Trifluoroacetate salt. |
|
Purity: | ≥95% (HPLC) |
|
Identity: | Determined by MS. |
|
Appearance: | Powder. |
|
Solubility: | Soluble in 30% Acetic Acid in Water (5 mg/ml). |
|
Shipping: | Shipped on Blue Ice |
|
Long Term Storage: | -20°C |
|
Handling: | Protect from moisture. |
|
Technical Info/Product Notes: | AIP (autocamtide-2-related inhibitory peptide, Prod. No. BML-P211) is a highly-specific and potent inhibitor of CaM kinase II. The sequence is derived from autocamtide-2 (Prod. No. BML-P101) but alanine is substituted for threonine at the 9-position. AIP at 1 µM completely inhibited CaM kinase II but did not affect PKC, PKA, CaMKIV and other brain extract kinases. Myristoylated AIP (Prod. No. BML-P212) is the same sequence as AIP but is N-terminal myristoylated to increase cell-permeability. |
|
Regulatory Status: | RUO - Research Use Only |
|
Product Literature References
Males and Females Differ in the Subcellular and Brain Region Dependent Regulation of Proteasome Activity by CaMKII and Protein Kinase A: R.K. Devulapalli, et al.; Neuroscience
418, 1 (2019),
Abstract;
The role of CaMKII in neuropathic pain and fear memory in chronic constriction injury in rats: Y. Qian, et al.; Int. J. Neurosci.
129, 146 (2019),
Abstract;
CaMKII regulates proteasome phosphorylation and activity and promotes memory destabilization following retrieval: T.J. Jarome, et al.; Neurobiol. Learn. Mem.
128, 103 (2016),
Application(s): Cell culture,
Abstract;